跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 56,629 条关于
“atypical chronic myeloid leukemia”
全部
56,629
临床试验
48,102
药物
586
机构
79
资讯
7,862
去年
Fedratinib Shows Efficacy in Rare Myeloid Neoplasms: Phase 2 Trial Results
去年
Olverembatinib Shows Promise in Heavily Pretreated Chronic Myeloid Leukemia
去年
FDA Approves Danziten, a Nilotinib Formulation for CML Without Mealtime Restrictions
去年
Non-ABL1 Mutations Impact Outcomes in Chronic Myeloid Leukemia
去年
FDA Approves Asciminib (Scemblix) for Newly Diagnosed Chronic Myeloid Leukemia
去年
FDA Approves Scemblix (asciminib) for Newly Diagnosed Chronic Myeloid Leukemia
2年前
Triplet Therapy Shows Promise in Advanced Chronic Myeloid Leukemia
去年
FDA Grants Accelerated Approval to Asciminib for Newly Diagnosed Chronic Myeloid Leukemia
去年
Ruxolitinib Plus TKI Therapy Shows Promise in Chronic Myeloid Leukemia
去年
Early Molecular Milestones Critical for Treatment-Free Remission Success in Chronic Myeloid Leukemia
第 1 页，共 787 页
上一页
下一页
